Stocks Health care AGMB
NASDAQ · Health careAgomab Therapeutics NV (AGMB)
We have not processed filings for Agomab Therapeutics NV yet. This page fills in on its own once we have read them.
What Agomab Therapeutics NV does
Agomab Therapeutics NV is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker AGMB.
Latest SEC filings
What Agomab Therapeutics NV has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 14, 2026
- September 11, 2026
- August 10, 2026
- August 6, 2026
- June 23, 2026
- May 27, 2026
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
- May 6, 2026Passive stake (5% or more) SCHEDULE 13G
- April 24, 2026
Questions about AGMB
What does Agomab Therapeutics NV do?
Agomab Therapeutics NV is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker AGMB.
When did Agomab Therapeutics NV last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on April 23, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the insider trade from September 15, 2026.
Similar companies
Follow AGMB
Get an email when Agomab Therapeutics NV files with the SEC: results, executive changes, material agreements and annual reports.
Follow AGMB: get an email when it filesWhere the numbers come from
Financial figures are the values Agomab Therapeutics NV tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.